Related Experiment Video
Updated: May 26, 2026
05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
Lingual thyroglossal duct cysts--a review
K S Muhammed Sameer1, Suravi Mohanty, Marjorie Mariam Ann Correa
1Department of Neonatal and Paediatric Surgery, St. John's Medical College Hospital, St. John's National Academy of Health Sciences, Bangalore 560034, India.
International Journal of Pediatric Otorhinolaryngology
|December 24, 2011
Summary
Lingual thyroglossal duct cysts (TGDC) are rare but important to diagnose. Management of these cysts should be individualized based on their location and presentation.
Area of Science:
- Otolaryngology
- Pediatric Surgery
- Developmental Biology
Background:
- Lingual thyroglossal duct cysts (TGDC) are rare congenital anomalies.
- They can be easily missed during routine clinical examinations.
- Early and accurate diagnosis is crucial for effective management.
Purpose of the Study:
- To report on a series of lingual TGDC cases.
- To review the existing literature on lingual TGDC.
- To discuss diagnostic and management strategies for lingual TGDC.
Main Methods:
- Retrospective analysis of 78 thyroglossal duct anomalies over 12 years.
- Identification and detailed review of lingual TGDC cases.
- Critical review of published English literature on diagnosis and management.
Main Results:
- Three cases of lingual TGDC were identified, all in females.
- Presentations varied from feeding difficulties in a neonate to cysts at the foramen caecum in older children.
- Imaging modalities like USG, CT, and MRI are essential for diagnosis.
Conclusions:
- Diagnosis and management of lingual TGDC require an individualized approach.
- The Sistrunk procedure is recommended for cysts near the hyoid bone.
- Complete cyst excision may be sufficient for other lingual TGDC cases.
Related Concept Videos
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:20Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...